edaravone

Generic: edaravone

Labeler: piramal critical care inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name edaravone
Generic Name edaravone
Labeler piramal critical care inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

edaravone 30 mg/100mL

Manufacturer
Piramal Critical Care Inc.

Identifiers & Regulatory

Product NDC 66794-259
Product ID 66794-259_40905b35-f5ad-1c99-e063-6294a90a22d4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216199
Listing Expiration 2026-12-31
Marketing Start 2024-07-08

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 66794259
Hyphenated Format 66794-259

Supplemental Identifiers

RxCUI
1924316
UNII
S798V6YJRP

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name edaravone (source: ndc)
Generic Name edaravone (source: ndc)
Application Number ANDA216199 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 30 mg/100mL
source: ndc
Packaging
  • 2 POUCH in 1 CARTON (66794-259-64) / 1 BAG in 1 POUCH / 100 mL in 1 BAG
source: ndc

Packages (1)

Ingredients (1)

edaravone (30 mg/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "40905b35-f5ad-1c99-e063-6294a90a22d4", "openfda": {"unii": ["S798V6YJRP"], "rxcui": ["1924316"], "spl_set_id": ["19862ae9-d6e1-70e6-e063-6394a90ae749"], "manufacturer_name": ["Piramal Critical Care Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 POUCH in 1 CARTON (66794-259-64)  / 1 BAG in 1 POUCH / 100 mL in 1 BAG", "package_ndc": "66794-259-64", "marketing_start_date": "20240708"}], "brand_name": "Edaravone", "product_id": "66794-259_40905b35-f5ad-1c99-e063-6294a90a22d4", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "66794-259", "generic_name": "Edaravone", "labeler_name": "Piramal Critical Care Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Edaravone", "active_ingredients": [{"name": "EDARAVONE", "strength": "30 mg/100mL"}], "application_number": "ANDA216199", "marketing_category": "ANDA", "marketing_start_date": "20240708", "listing_expiration_date": "20261231"}